Elotuzumab
Drug timelines are a Plus or Pro feature.
32 regulatory and trial events tracked for Elotuzumab, covering 2012-08-23 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide [Phase 3]